Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252167 | SCV000311827 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000252167 | SCV000540695 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
Labcorp Genetics |
RCV001515297 | SCV001723337 | benign | 46,XY sex reversal 9 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668525 | SCV001891221 | benign | not provided | 2019-04-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000252167 | SCV004122348 | likely benign | not specified | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001668525 | SCV005267901 | benign | not provided | criteria provided, single submitter | not provided |